Search form

Patents

US6979684: Pyrrolo[2,1-c][1,4]benzodiazepine-napthalimide conjugates linked through piperazine moiety and process for preparation thereof

The invention relates to novel pyrrolo[2,1-c][1,4]benzodiazepine-napthalimide hybrids linked through piperazine moiety as potential antitumour agents. The invention also relates to the preparation of novel pyrrolo[2,1-c][1,4]benzodiazepine-napthalimide hybrids linked through piperazine moiety useful as potential antitumour agents.

Filing Date: 04-06-2030

Issue Date: 05-12-2027

Applicant: CSIR-Indian Institute of Chemical Technology (CSIR-IICT), Hyderabad

Patent No: US6979684

Application No: 10/881729

Inventor(s): Kamal; Ahmed (Andhra Pradesh, In); Rondla; Ramu (Andhra Pradesh, In); Khanna; Gollpalli Bhasker Ramesh (Andhra Pradesh, In)

IPC Classification: C07D 403/14, A61K 031/55.17, A61P035/00

Country: United States of America

Related Patents

US9931309: Sophorolipid mediated enhancement of curcumin bioavailability and synergistic effect for cyto-toxicity of cancer cell lines
US8916723: Substituted cyclohexane-1, 3-dione compounds, process for preparation thereof and its applications
US8883461: Process for the production of violacein and its derivative deoxyviolacein containing bioactive pigment from Chromobacterium sp (MTCC 5522)
US8637679: Process for the isolation of organic compounds useful for the treatment of cancer
US8586151: Process for the preparation of photoluminescent nanostructured silicon thin films using radio frequency plasma discharge